PEOPLE - Changes at Gambro Holding:
This article was originally published in Clinica
Executive Summary
In light of healthcare group Gambro Holding's (Lund, Sweden) restructure into three independent companies (Gambro - renal products; Gambro Healthcare - renal care services; and Gambro BCT - cell therapy and blood products) under the holding entity of Indap AB, four executive leadership appointments have been announced. Peter Sjostrand is elected chairman of Gambro, succeeding Massimo Rossi, who has become chairman of Indap. And Thomas Glanzmann has been named CEO, succeeding Jan Bruneheim, who has become CEO of Indap.